NEW TARGETS FOR CANCER THERAPY AND/OR DIAGNOSIS AND NEW SCREENING TOOLS
    1.
    发明申请
    NEW TARGETS FOR CANCER THERAPY AND/OR DIAGNOSIS AND NEW SCREENING TOOLS 审中-公开
    用于癌症治疗和/或诊断和新筛选工具的新目标

    公开(公告)号:WO2010130825A3

    公开(公告)日:2011-01-13

    申请号:PCT/EP2010056645

    申请日:2010-05-14

    Abstract: The present invention relates to new targets for cancer therapy and / or diagnosis. In particular, the present invention provides new prophylactic and therapeutic targets and diagnostic markers for cancer, in particular solid tumours. In a first aspect, the present invention relates to methods of screening, design, engineering or otherwise producing a prophylactic or therapeutic agent for use in treatment of cancer. In a further aspect, the present invention relates to diagnostic methods as well as methods for stratification of cancer-therapy.

    Abstract translation: 本发明涉及用于癌症治疗和/或诊断的新靶标。 特别地,本发明提供了用于癌症,特别是实体瘤的新的预防和治疗靶标和诊断标志物。 在第一方面,本发明涉及筛选,设计,工程化或以其他方式制备用于治疗癌症的预防或治疗剂的方法。 另一方面,本发明涉及诊断方法以及癌症治疗分层方法。

    NEW TARGETS FOR CANCER THERAPY AND/OR DIAGNOSIS AND NEW SCREENING TOOLS
    2.
    发明申请
    NEW TARGETS FOR CANCER THERAPY AND/OR DIAGNOSIS AND NEW SCREENING TOOLS 审中-公开
    用于癌症治疗和/或诊断和新筛选工具的新目标

    公开(公告)号:WO2010130825A2

    公开(公告)日:2010-11-18

    申请号:PCT/EP2010/056645

    申请日:2010-05-14

    Abstract: The present invention relates to new targets for cancer therapy and / or diagnosis. In particular, the present invention provides new prophylactic and therapeutic targets and diagnostic markers for cancer, in particular solid tumours. In a first aspect, the present invention relates to methods of screening, design, engineering or otherwise producing a prophylactic or therapeutic agent for use in treatment of cancer. In a further aspect, the present invention relates to diagnostic methods as well as methods for stratification of cancer-therapy.

    Abstract translation: 本发明涉及用于癌症治疗和/或诊断的新靶标。 特别地,本发明提供了用于癌症,特别是实体瘤的新的预防和治疗靶标和诊断标志物。 在第一方面,本发明涉及筛选,设计,工程化或以其他方式制备用于治疗癌症的预防或治疗剂的方法。 另一方面,本发明涉及诊断方法以及癌症治疗分层方法。

Patent Agency Ranking